WPMY-1 Cells

WPMY-1 is a human prostatic myofibroblast cell line derived from the peripheral zone of the prostate. This cell line was established from the primary culture of prostatic fibroblasts of a 54-year-old Caucasian male patient. Notably, these cells are characterized by their spindle-shaped morphology and expression of smooth muscle actin, reflecting their myofibroblastic phenotype. WPMY-1 cells are an invaluable tool for studying the stromal-epithelial interactions in the prostate, particularly in the context of prostate cancer progression and development.

The WPMY-1 cell line has been utilized extensively in research focused on the paracrine and autocrine signaling mechanisms between prostate cancer cells and their microenvironment. These cells are known to secrete a range of cytokines and growth factors that can influence prostate cancer cell growth, invasion, and metastasis. The WPMY-1 line also serves as a robust model to investigate the effects of various pharmacological agents on the behavior of myofibroblasts within the tumor microenvironment. Furthermore, studies using WPMY-1 have contributed significantly to understanding the role of myofibroblasts in the pathophysiology of benign prostatic hyperplasia (BPH) and the fibrotic changes associated with this condition.

In addition to their use in cancer and fibrosis studies, WPMY-1 cells have also been employed in research exploring novel therapeutic targets and drug testing, providing insights into the complex interactions within the prostate gland that contribute to disease. This cell line retains several critical aspects of the parental cells’ phenotype and function, making it a versatile and valuable resource in prostate disease research.